Related Experiment Video
Updated: Jan 1, 2026
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Management of spontaneous coronary artery dissection complicated by cardiogenic shock using mechanical circulatory
Shilpa Sharma1, Samantha Polak2, Zachary George3
1Massachusetts General Hospital, Boston, Massachusetts.
Insights
This study shows that the Impella device is a feasible option for patients with spontaneous coronary artery dissection (SCAD) experiencing cardiogenic shock. It provided crucial hemodynamic support, leading to survival and recovery in all cases observed.
Area of Science:
- Cardiology
- Interventional Cardiology
- Mechanical Circulatory Support
Background:
- Spontaneous coronary artery dissection (SCAD) with cardiogenic shock has limited treatment options, often requiring risky revascularization.
- Mechanical circulatory support is being explored as a therapeutic alternative.
Purpose of the Study:
- To evaluate the feasibility and outcomes of using the Impella device in SCAD patients with cardiogenic shock.
- To assess the safety and efficacy of Impella in this specific patient population.
Main Methods:
- A multicenter case series involving Impella implantation in SCAD patients.
- Analysis of de-identified records from four cases, focusing on indications, outcomes, and complications.
Main Results:
- All four patients survived to hospital discharge with no major complications.
- Impella provided effective hemodynamic support, aiding recovery in cases of cardiogenic shock, including those with Takotsubo-like cardiomyopathy.
Conclusions:
- The Impella device demonstrates feasibility for managing cardiogenic shock in SCAD patients.
- It offers valuable procedural support, particularly in cases without ongoing ischemia, addressing a critical unmet need.
Objective:
The aim is to evaluate the feasibility of using mechanical circulatory support, specifically the Impella device, in spontaneous coronary artery dissection (SCAD) patients with cardiogenic shock.
Background:
The therapeutic options for managing SCAD complicated by cardiogenic shock are limited. Risky revascularization procedures are often necessary.
Methods:
This was a multicenter case series in the United States. Approximately 20 cases of Impella implantation in patients with SCAD are known. The implanting physician for each of these cases was contacted and de-identified records were requested. The records were analyzed for Impella indications, outcomes, and complications.
Results:
Records from four cases were received. All patients survived to hospital discharge and no major complications were observed. In two cases, cardiogenic shock developed in the absence of ongoing ischemia, suggesting a Takotsubo-like cardiomyopathy. In these cases, the Impella provided hemodynamic support until the patient's cardiac function recovered.
Conclusion:
Although a small case series, given the scarcity of SCAD cases complicated by cardiogenic shock and the limited therapies available to treat these patients, these data are of clinical value in highlighting the feasibility of Impella use in SCAD. The Impella can be valuable for procedural support and in cardiogenic shock, especially in cases without evidence of ongoing ischemia.
More Related Videos
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:24Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
01:26Acute Coronary Syndrome V: Nursing Management